Literature DB >> 30143432

Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects.

Bruno Ramos-Molina1, Daniel Castellano-Castillo1, Juan Alcaide-Torres1, Óscar Pastor2, Resi de Luna Díaz3, Jordi Salas-Salvadó4, Javier López-Moreno5, José C Fernández-García1, Manuel Macías-González1, Fernando Cardona6, Francisco J Tinahones1.   

Abstract

BACKGROUND: Bariatric surgery (BS) is the most effective treatment for severe obesity. Our group and others have previously reported that the type of BS (restrictive vs malabsorptive) can lead to different effects on the lipid profile and glucose homeostasis in morbidly obese patients. Furthermore, BS exerts significant changes in lipid metabolism, which are not yet fully understood and that might be dependent of surgical technique.
OBJECTIVE: The objective of this study was to evaluate the differential changes in the serum lipidomic profile of morbidly obese subjects who underwent two different BS techniques: sleeve gastrectomy (SG) (restrictive) and biliopancreatic diversion (BPD) (malabsorptive).
METHODS: This study included 37 morbidly obese patients (body mass index ≥ 40 kg/m2) who underwent either SG (n = 25) or BPD (n = 12). Serum lipid extracts were assessed at baseline and 6 months after BS and were analyzed in a ultra-high performance liquid chromatography time-of-flight mass spectrometry-based platform.
RESULTS: SG not only restores the circulating levels of fatty acids and glycerolipids to similar levels to those observed in nonobese subjects but also results in a consistent increase of phospholipid and sphingolipid species, ranging from antioxidant plasmalogens to lipotoxic ceramides. BPD, however, leads to an overall reduction in circulating fatty acids, glycerolipids, phospholipids and sphingolipids, and a substantial increase of bile acids.
CONCLUSION: Our lipidomic analysis suggests that the differential metabolic effects typically observed after restrictive vs malabsorptive BS procedures could be explained, at least partially, to BS-specific lipid changes and provides novel aspects of lipid remodeling in obesity during weight loss.
Copyright © 2018 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Lipidomics; Metabolomics; Obesity; Phospholipids; Sphingolipids

Mesh:

Substances:

Year:  2018        PMID: 30143432     DOI: 10.1016/j.jacl.2018.07.006

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  8 in total

1.  The Effect of One Anastomosis Gastric Bypass on Branched-Chain Fatty Acid and Branched-Chain Amino Acid Metabolism in Subjects with Morbid Obesity.

Authors:  Alicja Pakiet; Maciej Wilczynski; Olga Rostkowska; Justyna Korczynska; Patrycja Jabłonska; Lukasz Kaska; Monika Proczko-Stepaniak; Ewa Sobczak; Piotr Stepnowski; Faidon Magkos; Tomasz Sledzinski; Adriana Mika
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 2.  Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes.

Authors:  Jane Ha; Yeongkeun Kwon; Sungsoo Park
Journal:  Obes Surg       Date:  2021-07-27       Impact factor: 4.129

3.  Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability.

Authors:  Mia J Coleman; Luis M Espino; Hernan Lebensohn; Marija V Zimkute; Negar Yaghooti; Christina L Ling; Jessica M Gross; Natalia Listwan; Sandra Cano; Vanessa Garcia; Debbie M Lovato; Susan L Tigert; Drew R Jones; Rama R Gullapalli; Neal E Rakov; Euriko G Torrazza Perez; Eliseo F Castillo
Journal:  Metabolites       Date:  2022-05-11

Review 4.  Bariatric surgery and kidney disease outcomes in severely obese youth.

Authors:  Petter Bjornstad; Edward Nehus; Daniel van Raalte
Journal:  Semin Pediatr Surg       Date:  2020-01-20       Impact factor: 2.754

5.  Short-Term Effect of One-Anastomosis Gastric Bypass on Essential Fatty Acids in the Serum of Obese Patients.

Authors:  Adriana Mika; Maciej Wilczynski; Alicja Pakiet; Lukasz Kaska; Monika Proczko-Stepaniak; Marta Stankiewicz; Piotr Stepnowski; Tomasz Sledzinski
Journal:  Nutrients       Date:  2020-01-09       Impact factor: 5.717

Review 6.  Metabolomic signatures after bariatric surgery - a systematic review.

Authors:  Matilde Vaz; Sofia S Pereira; Mariana P Monteiro
Journal:  Rev Endocr Metab Disord       Date:  2021-12-02       Impact factor: 9.306

Review 7.  Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease.

Authors:  Paola Cuomo; Rosanna Capparelli; Antonio Iannelli; Domenico Iannelli
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

Review 8.  Sample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity.

Authors:  Ivan Liakh; Tomasz Sledzinski; Lukasz Kaska; Paulina Mozolewska; Adriana Mika
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.